Tremblant Capital Group’s Pfizer PFE Stock Holding History

Tremblant Capital Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,109,011	Closed	-$46.4M	–	48
2018 Q3	$46.4M	Buy	+1,109,011	New	+$42.7M	2.43%	18

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tremblant Capital Group's PFE Position: Q4 2018 in Review

Tremblant Capital Group sold out of Pfizer (PFE) in Q4 2018, closing a stake of 1,109,011 shares — an estimated $46.4M sold.

Tremblant Capital Group first reported a position in PFE in Q3 2018 and held it in 1 quarter. The position peaked at $46.4M in Q3 2018. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

Tremblant Capital Group reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
Tremblant Capital Group sold 1,109,011 Pfizer shares in Q4 2018, an estimated $46.4M.
Tremblant Capital Group first reported a position in Pfizer in Q3 2018 and held it in 1 quarter.
Tremblant Capital Group's Pfizer position peaked at $46.4M in Q3 2018.
2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Tremblant Capital Group's 13F filing for Q4 2018, filed 14 Feb 2019.